Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.068 | 0.8 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |